Comments by "Vierotchka" (@Vierotchka) on "Dr. John Campbell" channel.

  1. 75
  2. 65
  3. 63
  4. 54
  5. 48
  6. 37
  7. 36
  8. 35
  9. 34
  10. 32
  11. 24
  12. 23
  13. 18
  14. 16
  15. 16
  16. 15
  17. Here is what ZDoggMD says about REGEN-Cov-2: He got Regeneron’s monoclonal antibody cocktail. What is a monoclonal antibody and what does it do? So let me see if I can explain this simply. You’ve heard of convalescent plasma. Convalescent plasma is a fraction of the blood that’s removed from patients who’ve recovered from COVID-19. Presumably it contains antibodies that the patient has made against the corona SARS coronavirus 2. And by infusing it into a patient with active coronavirus disease, you presume that those antibodies will bind to the virus and help your immune response to contain the viral replication. Now what’s the downside of convalescent plasma? It has a mix of all kinds of stuff. So it has antibodies that don’t necessarily neutralize the virus, but they may bind to the virus and in some cases, that can actually enhance viral uptake. I’m not saying that’s what happens with SARS-CoV-2, but it does happen with things like Dengue. It’s so-called antibody mediated enhancement. So when you don’t bind to the right part of the virus, you can actually cause the virus to be recognized and pulled into the very cells it’s trying to infect. Now again, we don’t know that that occurs with SARS-CoV-2, but it’s certainly a risk and the data on convalescent plasma is still pretty soft. We’re waiting on really good prospective randomized control trials to see. And it’s not without risk because because of the other components you can have allergic reactions and that sort of thing, kind of similar to a transfusion reaction, right? But what did the president get? The president got monoclonal antibodies. These are designed to bind to the actual business end of the virus, the spike protein on the capsule of the virus that’s responsible for binding to human cells and bringing it into the cell. Those are neutralizing antibodies and what that means, and I’d encourage you to watch the interview I did with Paul Offit where we went through this, there’s a couple on my website, ZDoggMD.com. What that means is that the virus is actually knocked out by antibodies binding to it, by the immune response that’s triggered by that and so on. And they neutralize the virus. Now there’s a couple different antibodies there so that different variants, I won’t use the technical terms of the virus that might escape the initial antibodies might have less chance of that with multiple binging antibodies. Now what’s the status of this drug, right? It’s very expensive, it’s very hard to make, it’s very hard to scale up and only 10 people including the president have gotten it outside of the current ongoing randomized control trials in humans under compassionate use. The president is one of them. So he got something very, very special that’s not part of a trial that he got very early on, I think Friday, when he was not well enough and they actually had to take him by helicopter to Walter Reed. By the way, very concerning. Anyone who tells you that’s not concerning, and oh there’s just an abundance of caution. Something was going on with the president that concerned the doctors enough that they wanted to take these actions and that’s fine. You wanna do that.
    15
  18. 15
  19. 14
  20. 14
  21. 14
  22. 13
  23. 13
  24. 12
  25. 12
  26. 11
  27. 11
  28. 11
  29. 11
  30. 11
  31. 10
  32. 10
  33. 9
  34. 9
  35. 9
  36. 9
  37. Health officials worry about long-term effects of COVID-19 on kids More than one-third of all kids tested for COVID-19 in the state are testing positive. It’s even higher in Lee County at 46%. Now, some health officials are sounding the alarm about the potential longer-term effects of this virus on our kids. Health experts say we still have a lot to learn. A warning from Doctor Alina Alonso, the director of the Department of Health Palm Beach County: Just because you don’t see any COVID-19 symptoms in a child doesn’t mean damage hasn’t been done. “And while many of these especially younger children are asymptomatic when you take x-rays of their lungs, down in Miami and other places across the country, they’re seeing that there is damage to the lungs in these asymptomatic children.” While Alonso says there’s proof asymptomatic children are suffering lung damage now, she and other warn we also need to start thinking about the lasting consequences these kids may have to live with. “We may have to deal with this virus for decades because of not just the survivors coming back with consequences, but also those who were the silent, infected individuals,” said Dr. Bindu Mayi, professor of microbiology at NSU’s College of Medical Sciences. On Thursday, when asked about the issue, Governor Ron DeSantis cited a lack of studies and evidence as a reason we shouldn’t be too concerned yet. "It would be irresponsible for me to say, ‘There will never be any long term’ because we just don’t know. But it’s also problematic to say in 20 years, there’s going to be all of these problems because we just don’t know that." Instead, the governor says we should stick to the proven facts, like focusing on the best strategy to avoid infection: wearing a mask and social distancing. Experts say one reason we know so little about the virus is because of how it spreads throughout the body. It can impact multiple organs and body systems in different ways in different people. https://www.winknews.com/2020/07/17/health-officials-worry-about-long-term-effects-of-covid-19-on-kids/
    9
  38. 9
  39. 9
  40. 9
  41. 9
  42. 8
  43. 8
  44. Golikova named the reasons for the increase in the incidence of COVID-19 in Russia The main reasons for the incidence of COVID-19 in Russia are participation in public events and non-observance of the mask regime. This was announced on September 29 by Deputy Prime Minister Tatyana Golikova at a meeting with President Vladimir Putin. “If we do not want the restrictions that we had in March-April - at the beginning of May this year, then we must strictly comply with all [sanitary] requirements,” Golikova said. She noted that the daily increase in the incidence of COVID-19 in Russia increased by 1.7 times - from 3.1 to 5.5 times per 100 thousand population. According to surveys, 80-85% of patients say that the reason is their non-observance of the mask regime and participation in mass events. “The rate of increase in the incidence in the country as a whole is kept at the level of 0.5-0.7%. <...> The spread of coronavirus infection, the so-called reproduction rate, is 1.1 in Russia today. This means that it has increased compared to the figure [which was recorded] three weeks ago. Today, only 41 regions have this figure below one, ”Golikova stressed. She also said that at the moment in Russia there are opportunities to increase the production of test kits to detect coronavirus infection. In addition, according to her, the free bed capacity for patients with COVID-19 is currently 31%. Earlier on the same day, Rospotrebnadzor said that the situation with the spread of coronavirus infection in Russia is under control, but depending on the number of new cases, new restrictions may be introduced. The day before, Putin said that the fight against the coronavirus was not over yet and that it was impossible to lose vigilance. According to him, the country ranks 40th in the world in terms of the number of cases per 100 thousand citizens, and in terms of the number of deaths - 100th place, writes Gazeta.ru. Source: https://iz.ru/1067024/2020-09-29/golikova-nazvala-prichiny-rosta-zabolevaemosti-covid-19-v-rossii
    8
  45. 8
  46. 8
  47. 8
  48. 8
  49. 8
  50. 7
  51. 7
  52. 7
  53. 7
  54. 7
  55. Health officials worry about long-term effects of COVID-19 on kids More than one-third of all kids tested for COVID-19 in the state are testing positive. It’s even higher in Lee County at 46%. Now, some health officials are sounding the alarm about the potential longer-term effects of this virus on our kids. Health experts say we still have a lot to learn. A warning from Doctor Alina Alonso, the director of the Department of Health Palm Beach County: Just because you don’t see any COVID-19 symptoms in a child doesn’t mean damage hasn’t been done. “And while many of these especially younger children are asymptomatic when you take x-rays of their lungs, down in Miami and other places across the country, they’re seeing that there is damage to the lungs in these asymptomatic children.” While Alonso says there’s proof asymptomatic children are suffering lung damage now, she and other warn we also need to start thinking about the lasting consequences these kids may have to live with. “We may have to deal with this virus for decades because of not just the survivors coming back with consequences, but also those who were the silent, infected individuals,” said Dr. Bindu Mayi, professor of microbiology at NSU’s College of Medical Sciences. On Thursday, when asked about the issue, Governor Ron DeSantis cited a lack of studies and evidence as a reason we shouldn’t be too concerned yet. "It would be irresponsible for me to say, ‘There will never be any long term’ because we just don’t know. But it’s also problematic to say in 20 years, there’s going to be all of these problems because we just don’t know that." Instead, the governor says we should stick to the proven facts, like focusing on the best strategy to avoid infection: wearing a mask and social distancing. Experts say one reason we know so little about the virus is because of how it spreads throughout the body. It can impact multiple organs and body systems in different ways in different people. https://www.winknews.com/2020/07/17/health-officials-worry-about-long-term-effects-of-covid-19-on-kids/
    7
  56. 7
  57. 7
  58. 6
  59. 6
  60. 6
  61. 6
  62. 6
  63. 6
  64. 6
  65. 6
  66. 6
  67. 6
  68. 6
  69. 6
  70. 5
  71. 5
  72. 5
  73. 5
  74. 5
  75. 5
  76. 5
  77. 5
  78. 5
  79. 5
  80. 5
  81. 5
  82. 5
  83. 5
  84. 5
  85. 5
  86. 5
  87. 5
  88. 5
  89. 5
  90. 5
  91. Ethnically, the residents of Norway are predominantly Norwegians, a North Germanic ethnic group descent. In Northern Norway live the Sami, who claim descent from people who settled the area around 8,000 years ago, probably from continental Europe through the Norwegian coast and through Finland along the inland glaciers. As of 2012, an official government study shows that 86.2% of the total population are ethnic Norwegians.[11] The national minorities of Norway include Scandinavian Romani, Roma, Jews, and Kvener, as well as a small Finnish community. In the last decades, Norway has become home to increasing numbers of immigrants, foreign workers, and asylum-seekers from various parts of the world. Norway had a steady influx of immigrants from South Asia (mostly Pakistanis and Sri Lankans), East Asia (mainly Chinese), and Southeast Asia/Pacific Islands (e.g. Filipinos), Eastern Europe (e.g. Russians) and (Central Europe Poles), Southern Europe (Greeks, Albanians and people from former Yugoslavia etc.), and Middle East countries (especially Iraqis and Kurdish Iranians), as well as Somalis, Turks, Moroccans, and some Latin Americans. After ten Eastern European and Baltic countries joined the EU in 2004, there has also been a substantial influx of people from Poland, Estonia, Latvia and Lithuania. Immigrants constituted 13% of the population at the start of 2015, and an additional 2.6% were born in Norway by immigrant parents[12] (up from 8,3% and 1,5% in 2006[13]). The same year, 19% of births in Norway were to immigrant parents.[12] In 2006, non-Western immigrants constituted 75% of the total number of immigrants. They contribute much of the population growth. Among people of African descent in Oslo, almost 60% are younger than 30, compared to 20% of those of North American background.[13] As of 2012, an official government study shows that more than 660,000 individuals (13.8%) are migrants and their descendants (110,000 second generation migrants born in Norway).[11] Of these 660,000 immigrants and their descendants: 335,000 (51%)[11] have a Western background (Australia, New Zealand, North America, elsewhere in Europe) 325,000 (49%)[11] have a non-Western background. In 2012, of the total 660 000 with immigrant background, 407,262 had Norwegian citizenship (62.2 percent).[14] Immigrants were represented in all Norwegian municipalities. The cities or municipalities with the highest share of immigrants in 2012 was Oslo (26 percent) and Drammen (18 percent).[15] The share in Stavanger was 16%.[15] According to Reuters, Oslo is the "fastest growing city in Europe because of increased immigration".[16] In recent years, immigration has accounted for most of Norway's population growth.[13]
    5
  92. 5
  93. 5
  94. 5
  95. 5
  96. 5
  97. 5
  98. 5
  99. 5
  100. 5
  101. 5
  102. 5
  103. *Russia's COVID-19 vaccine 'ready,' says official * Russia plans to start mass production of vaccine against novel coronavirus in August 21.07.2020 MOSCOW Russia’s first vaccine against the novel coronavirus is ready, a government official said on Tuesday. Ruslan Tsalikov, the first deputy defense minister, said two groups of volunteers have successfully completed clinical trials, with all of them having “built up immunity.” “At the time of discharge, all the volunteers, without exception, built up immunity to the coronavirus and felt well. Thus, the first domestic vaccine against a new coronavirus infection is ready,” he said in an interview with AiF newspaper. The vaccine, he said, was jointly developed by the Gamaleya National Research Centre for Epidemiology and Microbiology and the Main Military Clinical Burdenko Hospital. Tsalikov added that the Russian military has “significant scientific potential and extensive experience” in vaccine development, citing as an example its contributions to developing a vaccine against the Ebola virus. Production approval in August Russian companies may get the go-ahead for mass production of the COVID-19 vaccine by August, another official said. Kirill Dmitriyev, head of the Russian Direct Investment Fund (RDIF), said the next phase of clinical trials will end on Aug. 3, after which the third phase will be launched in Russia, Turkey, the UAE, and Africa. “We expect approval from regulatory bodies in the Russian Federation in August, and immediately after that we plan to start mass production at the sites of the RDIF’s R-Pharm and Alium companies. We expect approval in other partner countries in September,” he said in a statement. The official said Russia aims to produce 200 million doses of the vaccine by the end of the year in partnership with five other countries, which he did not name. According to Dmitriyev, 30 million doses will be made in Russia and the rest in the other countries. *He added that Russia also plans to produce the vaccine being jointly developed by the Oxford University and pharmaceutical company AstraZeneca. * The Russian vaccine will be delivered together with a unique patented test that identifies special antibodies in the human body that attack the crown-like spikes of the coronavirus, the official said. “I was myself inoculated with the Russian vaccine. I developed a stable immunity after 20 days, before getting the second maintenance dose, which should extend the immunity to two years,” he said. Meanwhile, the daily figure of new coronavirus cases in Russia remained below 6,000 on Tuesday. As many as 5,842 more infections raised the country’s total count to 783,328, with fatalities now over 12,500 and recoveries exceeding 562,000. https://www.aa.com.tr/en/europe/russias-covid-19-vaccine-ready-says-official/1917666
    5
  104. 5
  105. 4
  106. 4
  107. 4
  108. 4
  109. 4
  110. 4
  111. 4
  112. 4
  113. 4
  114. 4
  115. 4
  116. 4
  117. 4
  118. 4
  119. 4
  120. 4
  121. 4
  122. 4
  123. 4
  124. With regard to Russia and Putin, Doctor, you are wrong - have you given in to the western mendacious Russophobic propaganda? Russia has created a reserve of 700,000 test kits that it will regularly replenish. And the coronavirus council announced yesterday it is allotting 1.4 billion rubles ($17.7 million) to VECTOR, the antiplague facility, and several Rospotrebnadzor labs to spur vaccine and drug development. To cope with a rising tide of patients, Russia’s federal government is building a new hospital on Moscow’s outskirts. Authorities have called on Moscow residents over age 65 to self-isolate at home—an admonishment that Russian President Vladimir Putin, 67, exempted himself from. But Putin on the 24th of March donned protective gear while visiting a hospital treating COVID-19 patients, and yesterday he ordered all nonessential workplaces to close from 28 March to 5 April, declaring that “the safest thing is to be at home now.” Today, the government suspended international travel into and out of Russia—starting tomorrow—except for charter flights for bringing expatriates home. Sick people who had contact with foreigners have been isolated in hospitals starting in early February. So, starting last month, hospitals were full of suspected patients, and their relatives were warned about the danger of infection. [Russia’s coronavirus commission yesterday said 112,000 people are in self-isolation in their homes.] There is some community transmission, but the majority of patients who tested positive arrived from Europe. Unfortunately, measures to restrict air travel with Europe were introduced too late, when outbreaks had already occurred in Italy and other countries. [The first genome of the novel coronavirus sequenced from a Russian patient—a woman in St. Petersburg—placed it in a clade circulating in Europe.] Over the past week, Russia has sent 15 cargo planes to Italy carrying 600 ventilators, 100 military medical specialists, and eight medical teams. The teams sent to Italy include some of Russia's top virologists and epidemiologists, including those who had participated in international efforts to combat the spread of Ebola.
    4
  125. 4
  126. 4
  127. 4
  128. 4
  129. 4
  130. 4
  131. The majority of the population are ethnic Swedes, or people who can trace their ethnicity to Swedish stock going back at least 12 generations. The Sweden Finns are a large ethnic minority comprising approximately 50,000 along the Swedish-Finnish border, and 450,000 first and second-generation immigrated ethnic Finns, mainly living in the Mälaren Valley region. Meänkieli Finnish has official status in parts of northern Sweden near the Finnish border. In addition, Sweden's indigenous population groups include the Sami people, who have a history of practicing hunting and gathering and gradually adopting a largely semi-nomadic reindeer herding lifestyle. They have been present in Fenno-Scandinavia from at earliest 5000 years [16] to at latest around 2650 years [17]. Today, the Sami language holds the status of official minority language in four municipalities in the Norrbotten county. In addition to the Sami, Tornedalers, and Sweden Finns, Jewish and Roma people have national minority status in Sweden.[18] There are no official statistics on ethnicity, but according to Statistics Sweden, around 3,311,312 (32.3%) inhabitants of Sweden were of a foreign background in 2018, defined as being born abroad or born in Sweden with at least one parent born abroad.[19] The most common countries of origin were Syria (1.82%), Finland (1.45%), Iraq (1.41%), Poland (0.91%), Iran (0.76%) and Somalia (0.67%).[20] Sweden subsequently has one of the oldest populations in the world, with the average age of 41.1 years.[21]
    4
  132. Since 1980, the number of Danes has remained constant at around 5 million in Denmark and nearly all the population growth from 5.1 up to the 2018 total of 5.8 million was due to immigration.[1] According to 2017 figures from Statistics Denmark, 86.9%[2][3] of Denmark's population of over 5,760,694 was of Danish descent, defined as having at least one parent who was born in Denmark and has Danish citizenship.[4][2] The remaining 13.1% were of a foreign background, defined as immigrants or descendants of recent immigrants. With the same definition, the most common countries of origin were Poland, Turkey, Germany, Iraq, Romania, Syria, Somalia, Iran, Afghanistan, and Yugoslavia and its successor states.[citation needed] More than 752,618 individuals (13.1%)[2][3] are migrants and their descendants (146,798 second generation migrants born in Denmark[3]). Of these 752,618[2] immigrants and their descendants: 267,606 (36%)[3] have a Western background (Norway, Germany, Bosnia and Herzegovina, UK, Poland, Romania and Iceland; definition: EU countries, non-EU Nordic countries, Andorra, Liechtenstein, Monaco, San Marino, Switzerland, Vatican State, Canada, USA, Australia and New Zealand). 485,012 (64%)[3] have a non-Western background (Turkey, Romani, Iraq, Iran, Kurdistan, Pakistan, Thailand and Somalia; all other countries). Ethnic groups See also: Armenians in Denmark, Chinese people in Denmark, Greeks in Denmark, History of the Jews in Denmark, Arabs in Denmark, Iraqis in Denmark, Pakistanis in Denmark, and Turks in Denmark Non-Scandinavian ethnic minorities include: Afghans Inuit (Greenlandic) from the territory of Greenland Turks Arabs (i.e. Palestinians, followed by Moroccans, Syrians, Yemenis, Egyptians, Iraqis and Jordanians) Vietnamese Thai Lebanese Jews Chinese Pakistanis (including Pashtuns) Iranians/Kurdistanis Somalis Ethiopians Sudanese Indians Chileans (the most numerous of Latin American nationalities) Bosniaks Poles Albanians Bangladeshis Historic minorities Ethnic minorities in Denmark include a handful of groups: Approximately 15,000 people[6] in Denmark belong to a German minority traditionally referred to as hjemmetyskere meaning "domestic Germans" in Danish, and as Nordschleswiger in German. This minority of Germans hold Danish citizenship and self-identify as Germans. Many of them speak German or Low German as their home language. There are also several thousand German citizens and other ethnic Germans residing in Denmark with no historical connection to this group. An estimated 23,000 people[7] in Denmark proper are ethnic Faroese, while 19,000 Greenlanders reside permanently in Denmark.[8] Many of these use the Faroese and Greenlandic languages, respectively, as their first language. All residents of the Kingdom (viz. Denmark proper, the Faroe Islands and Greenland) holds Danish citizenship, unless they inherit or otherwise receive a foreign citizenship. The religiously affiliated Danish Jews number around 7,000.[9] Secular Jews and unaffiliated ethnic Jews in Denmark number several thousand. There are approximately 15,000-20,000 Romani people with historical ties to Denmark, excluding recent immigrants and their immediate descendants. Modern minorities Rank Country of origin[10] Population (2020)[11] 1. Turkey 73,906 2. Poland 48,719 3. Syria 43,313 4. Germany 34,727 5. Iraq 33,712 6. Romania 33,625 7. Pakistan 30,634 8. Lebanon 29,747 9. Bosnia and Herzegovina 23,380 10. Iran 21,863 11. Somalia 21,166 12. Afghanistan 19,551 13. Yugoslavia 17,733 14. Norway 17,517 15. United Kingdom 17,290 16. Sweden 16,825 17. Vietnam 16,036 18. India 15,405 19. Lithuania 15,139 20. Mainland China 15,103
    4
  133. 4
  134. 4
  135. 4
  136. 4
  137. 4
  138. 4
  139. 4
  140. 4
  141. 4
  142. 4
  143. 4
  144. 4
  145. 4
  146. 4
  147. 4
  148. 4
  149. 4
  150. 4
  151. 4
  152. 4
  153. 4
  154. 4
  155. 4
  156. 4
  157. 4
  158. 4
  159. 4
  160. 4
  161. 3
  162. 3
  163. 3
  164. 3
  165. 3
  166. 3
  167. 3
  168. 3
  169. 3
  170. 3
  171. 3
  172. 3
  173. 3
  174. 3
  175. 3
  176. 3
  177. 3
  178. 3
  179. 3
  180. 3
  181. 3
  182. 3
  183. This is why I trust Sputnik V way above all the other Covid-19 vaccines currently being developed. Excerpts: Adenoviral vectors are considered extremely safe, and are some of the easiest to engineer. Vectors are viruses that have had the gene responsible for replication removed. Therefore, they no longer pose any threat of infection. Scientists use vectors to transport genetic material from a different virus -the one that is being vaccinated against -into a human cell. [snip] Scientists from the Gamaleya Center have been working on adenoviral vector-based vaccines since the 1980s, and now lead the world in developing these types of vaccines. Another adenoviral vector-based vaccine against Middle East Respiratory Syndrome (MERS) is in the advanced stages of clinical trials. Many other COVID-19 vaccine candidates also do use adenoviral vectors, but none uses the two-vector platform developed by the Gamaleya Center. During the vaccine creation process, a gene with the code of a coronavirus S (spike) protein is inserted into an adenoviral vector. This inserted component is safe for the human body, but still helps the immune system to react and produce the antibodies that protect us from infection. Using adenovirus vectors, scientists at the Gamaleya Center successfully created, and were issued the Russian Federation Ministry of Healthcare certificate of registration for, a vaccine against the Ebola fever that incorporates adenovirus vectors. Source: https://sputnikvaccine.com/about-vaccine/human-adenoviral-vaccines/
    3
  184. 3
  185. 3
  186. The largest minority group in Finland is the Swedish-speaking Finns, who in 2018 numbered about 282,300, with all Swedish speakers in the country making a total of 288,400 which is 5.2% of the total population.[27] Municipalities are classified as either unilingual or bilingual with a majority language. Majority of Swedish-speakers live in unilingual Swedish-speaking municipalities. These municipalities are found in coastal areas, from Ostrobothnia to the southern coast, and in the archipelago of Åland.[7] Pakistanis Pakistanis form the fourth largest South Asian immigrant group in Finland after Afghans, Indians and Nepalis. In 1971 around 100 Pakistanis came to Finland for jobs. Finland didn't want cheap labour so they turned them all down.[29] As of the 31st December 2018 there are 3,736 people of Pakistani background living in Finland, 3,065 of these people were born in Pakistan. Russians Russians in Finland had come from two major waves. About 5,000 originate from a population that immigrated in the 19th and early 20th centuries, when Finland was a grand duchy of Imperial Russia. Another consisted of those who immigrated after the dissolution of the Soviet Union. A significant catalyst was the right of return, based on President Koivisto's initiative that people of Ingrian ancestry would be allowed to immigrate to Finland.[33] About 30,000 people have citizenship of the Russian Federation (2015)[34] and Russian is the mother language of about 70,000 people in Finland, which represents about 1.3% of the population.[1][24] Romani Further information: Finnish Kale Romani people, also called Kale and Roma, have been present in Finland since the second half of the 16th century. With their unusual dress, unique customs, and specialized trades for earning their livelihood, Roma have stood out, and their stay in the country has not been an easy one. They have suffered periodic harassment from the hands of both private citizens and public officials, and the last of the special laws directed against them was repealed only in 1883. Even in the second half of the 1980s, Finland's 5,000 to 6,000 Romani remained a distinct group, separated from the general population both by their own choice and by the fears and the prejudices many Finns felt toward them.[7] Finnish Roma, like Roma elsewhere, chose to live apart from the dominant societal groups. A Roma's loyalty was to his or her family and to their people in general. Marriages with non-Roma were uncommon, and the Roma's own language, spoken as a first language only by a few in the 1980s, was used to keep outsiders away. An individual's place within Roma society was largely determined by age and by sex, old males having authority. A highly developed system of values and a code of conduct governed a Roma's behavior, and when Roma sanctions, violent or not, were imposed, for example via "blood feuds," they had far more meaning than any legal or social sanctions of Finnish society.[7] Unlike the Sami, who lived concentrated in a single region, the Romani lived throughout Finland. While most Sami wore ordinary clothing in their everyday life, Romani could be identified by their dress; the men generally wore high boots and the women almost always dressed in very full, long velvet skirts. Like most Sami, however, Roma also had largely abandoned a nomadic way of life and had permanent residences. Romani men had for centuries worked as horse traders, but they had adapted themselves to postwar Finland by being active as horse breeders and as dealers in cars and scrap metal. Women continued their traditional trades of fortune telling and handicrafts.[7] Since the 1960s, Finnish authorities have undertaken measures to improve the Romani's standard of life. Generous state financial arrangements have improved their housing. Their low educational level (an estimated 20 percent of adult Romani could not read) was raised, in part, through more vocational training. A permanent Advisory Commission on Gypsy Affairs was set up in 1968, and in 1970 racial discrimination was outlawed through an addition to the penal code. The law punished blatant acts such as barring Romani from restaurants or shops or subjecting them to unusual surveillance by shopkeepers or the police.[7] Jews Further information: History of the Jews in Finland There are about 1,300 Jews in Finland, 800 of whom live in Helsinki and most of the remainder live in Turku. During the period of Swedish rule, Jews had been forbidden to live in Finland. Once the country became part of the Russian Empire, however, Jewish veterans of the Tsarist army had the right to settle anywhere they wished within the empire. Although constrained by law to follow certain occupations, mainly those connected with the sale of clothes, the Jewish community in Finland was able to prosper, and by 1890 it numbered around 1,000. Finnish independence brought complete civil rights, and during the interwar period there were some 2,000 Jews in Finland, most of them living in urban areas in the south. During World War II, Finnish authorities refused to deliver Jews to the Third Reich, and the country's Jewish community survived the war virtually intact. By the 1980s, assimilation and emigration had significantly reduced the size of the community, and it was only with some difficulty that it maintained synagogues, schools, libraries, and other pertinent institutions.[7] Tatars The community of Finnish Tatars numbers only about 800. The Tatars first came to Finland from the Russian Volga region near Nizni Novgorod's Tatar villages in the mid-19th century and have remained there ever since, active in commerce. The Tatars in Finland fully integrated into the Finnish society at the same time they preserved their religion, mother tongue and ethnic culture.[35] Karelians In 2011 there were about 30.000 people who indentified as Karelian in Finland. About 5.000 of them are fluent or native in the Karelian language but about 25.000 of them can speak Karelian. The Karelians are a closely related group to Finns. Karelians in Finland mostly live in a Diasphora around the country and in North-Karelia. All dialects of Karelian are spoken in Finland.[36] Before 2009 Karelian was taught as a dialect of Finnish but in 2009 Karelian got an official status as a language in Finland.[37]
    3
  187. 3
  188. 3
  189. 3
  190. 3
  191. 3
  192. 3
  193. 3
  194. All about Sputnik V: https://sputnikvaccine.com/ Russian scientist behind COVID-19 vaccine defends 'wartime' roll-out MOSCOW (Reuters) - Russia plans to share preliminary results of its COVID-19 vaccine trial based on the first six weeks of monitoring participants, raising the tempo in an already frenzied global race to end the pandemic. Alexander Gintsburg, head of the Gamaleya Institute that produced the Sputnik V vaccine, told Reuters that the pace of its development was necessary under the “wartime” conditions of a pandemic but no corners were being cut. Russia has pushed ahead with its potential COVID-19 vaccine at top speed with mass public vaccinations alongside the main human trial, raising concerns among some observers that it was prioritising national prestige over solid science and safety. “People are dying just like during a war,” said Gintsburg, holding a crystal model of a coronavirus in his hand. “But this fast-tracked pace is not synonymous, as some media have suggested, with corners being cut. No way.” Sitting in his wood-panelled office at the institute in Moscow, Gintsburg said his team had been set a tight deadline to produce a vaccine but all the guidelines for testing Sputnik V’s safety and efficacy had been followed. The plan to publish interim results based on the first 42 days of monitoring volunteers means Russia has a high chance of becoming the first worldwide to announce any data from a final-stage trial, which is known as Phase III. The first of 5,000 volunteers was vaccinated on Sept. 9, which means interim results could be issued some time after Oct. 21. Russia’s sovereign wealth fund, which has invested in the vaccine’s roll-out, has said it expects interim results to be published in October or November. *PUBLIC INTEREST * Several Western developers are conducting final-stage trials that have already been going on for more than 42 days but have not published any interim results. Drugmakers have said they would wait until they have enough infections to get a reliable read-out from the data before publication, rather than assigning a specific date. Gintsburg said there was a public interest argument for sharing interim results after 42 days as they would show the general trend in the data. “For me, for example, it is too short. But for people who are interested in how things are going, it is already too long.” Gintsburg said volunteers would be monitored for 180 days after the last of 40,000 participants was vaccinated. Six months on, his team planned to tally up final results and then publish them in an international journal. More at https://www.reuters.com/article/us-health-coronavirus-russia-vaccine/russian-scientist-behind-covid-19-vaccine-defends-wartime-roll-out-idUSKBN26K0QL
    3
  195. 3
  196. 3
  197. 3
  198. 3
  199. 3
  200. 2
  201. 2
  202. 2
  203. 2
  204. 2
  205. Why hydroxychloroquine’s appeal endures despite evidence it doesn’t work for Covid-19 https://medcitynews.com/2020/08/why-hydroxychloroquines-appeal-endures-despite-evidence-it-doesnt-work-for-covid-19/?rf=1 https://www.leparisien.fr/societe/irresponsable-la-premiere-etude-de-didier-raoult-mise-a-mal-par-une-revue-critique-16-07-2020-8354028.php https://medicalxpress.com/news/2020-08-hydroxychloroquine-treatment-covid-.html https://www.sciencealert.com/here-s-why-hydroxychloroquine-doesn-t-block-the-coronavirus-in-human-lung-cells https://www.nbcnews.com/health/health-news/hydroxychloroquine-covid-19-scientists-say-it-s-time-stop-promoting-n1235347 https://www.nejm.org/doi/full/10.1056/NEJMoa2019014 https://www.statnews.com/2020/07/16/new-covid-19-study-despite-flaws-adds-to-case-against-hydroxychloroquine/ https://www.acpjournals.org/doi/10.7326/M20-4207 https://theconversation.com/why-hydroxychloroquine-and-chloroquine-dont-block-coronavirus-infection-of-human-lung-cells-143234 https://www.sciencenews.org/article/covid-19-coronavirus-hydroxychloroquine-no-evidence-treatment https://www.theadvocate.com/baton_rouge/news/coronavirus/article_785b51a6-d603-11ea-b1f7-9726f23253aa.html https://medcitynews.com/2020/07/hydroxychloroquine-flunks-phase-iii-trial-in-mild-to-moderate-covid-19/ https://www.forbes.com/sites/alexledsom/2020/07/19/hydroxychloroquine-europe-turns-away-from-doctor-who-championed-drug-with-irresponsible-study/#3948cbddf912 https://www.news-medical.net/news/20200719/Hydroxychloroquine-is-not-indicated-for-COVID-19-under-any-circumstances.aspx https://www.counterpunch.org/2020/08/04/statement-from-yale-faculty-on-hydroxychloroquine-and-its-use-in-covid-19/ https://www.technologynetworks.com/drug-discovery/news/why-lopinavir-and-hydroxychloroquine-are-ineffective-in-covid-19-patients-337291 https://en.mercopress.com/2020/07/25/brazil-study-confirms-hydroxychloroquine-is-ineffective-to-treat-covid-19 https://www.pharmacytimes.com/publications/issue/2020/july2020/patient-experiences-cardiac-arrest-when-taking-2-medications "...there is a cardiac risk factor for sudden death from arrhythmias" https://spectrumlocalnews.com/nys/central-ny/politics/2020/07/29/ub-doctors-give-facts-about-hydroxychloroquine-and-covid https://www.ajmc.com/view/caution-strongly-recommended-when-using-chloroquine-hydroxychloroquine-in-patients-with-cardiovascular-disease-covid19 https://www.hug.ch/sites/interhug/files/structures/coronavirus/documents/hydroxy-chloroquine_et_covid-19.pdf https://www.sciencedirect.com/science/article/pii/S0924857920302338#!
    2
  206. 2
  207. 2
  208. Health officials worry about long-term effects of COVID-19 on kids More than one-third of all kids tested for COVID-19 in the state are testing positive. It’s even higher in Lee County at 46%. Now, some health officials are sounding the alarm about the potential longer-term effects of this virus on our kids. Health experts say we still have a lot to learn. A warning from Doctor Alina Alonso, the director of the Department of Health Palm Beach County: Just because you don’t see any COVID-19 symptoms in a child doesn’t mean damage hasn’t been done. “And while many of these especially younger children are asymptomatic when you take x-rays of their lungs, down in Miami and other places across the country, they’re seeing that there is damage to the lungs in these asymptomatic children.” While Alonso says there’s proof asymptomatic children are suffering lung damage now, she and other warn we also need to start thinking about the lasting consequences these kids may have to live with. “We may have to deal with this virus for decades because of not just the survivors coming back with consequences, but also those who were the silent, infected individuals,” said Dr. Bindu Mayi, professor of microbiology at NSU’s College of Medical Sciences. On Thursday, when asked about the issue, Governor Ron DeSantis cited a lack of studies and evidence as a reason we shouldn’t be too concerned yet. "It would be irresponsible for me to say, ‘There will never be any long term’ because we just don’t know. But it’s also problematic to say in 20 years, there’s going to be all of these problems because we just don’t know that." Instead, the governor says we should stick to the proven facts, like focusing on the best strategy to avoid infection: wearing a mask and social distancing. Experts say one reason we know so little about the virus is because of how it spreads throughout the body. It can impact multiple organs and body systems in different ways in different people. https://www.winknews.com/2020/07/17/health-officials-worry-about-long-term-effects-of-covid-19-on-kids/
    2
  209. 2
  210. 2
  211. 2
  212. 2
  213. 2
  214. 2
  215. 2
  216. 2
  217. 2
  218. 2
  219. 2
  220. 2
  221. 2
  222. 2
  223. 2
  224. 2
  225. 2
  226. 2
  227. 2
  228. 2
  229. 2
  230. 2
  231. 2
  232. 2
  233. 2
  234. 2
  235. 2
  236. 2
  237. 2
  238. 2
  239. 2
  240. 2
  241. 2
  242. 2
  243. 2
  244. 2
  245. 2
  246. The U.S. May Be Heading To A Second (Or Even Fourth) Wave Of The Coronavirus Epidemic. Here’s What That Means Topline: Some scientists and commentators, like leading coronavirus expert Dr. Anthony Fauci, have referenced the possibility of a “second wave” of the coronavirus pandemic in the fall, following expected slower growth rates of COVID-19 cases during the summer, while infectious disease specialist Dr. Kent Sepkowitz suggests a “fourth wave” may already be upon us. Here’s what you need to know. The Centers For Disease Control yesterday warned that the United States may face a second wave of the virus come fall, as happened in 2009 with swine flu.  By this time, many initial cases will have resolved or ended in death but a large swath of the population will still be susceptible to the infection, said CDC director Dr. Robert Redfield.  Kent Sepkowitz, an infectious disease specialist for Memorial Sloan Kettering Cancer Center, in an op-ed on  CNN, offered an alternative definition for tracking coronavirus waves.  The first wave, according to Sepkowitz, started on the West Coast, where coronavirus ravaged a Washington-state nursing home, and in the second wave, the virus hit New York City, the country’s current epicenter, where nearly 50,000 patients have been infected so far.  In the third wave, coronavirus moved to other urban centers now emerging as “hot spots,” like New Orleans, Detroit and Atlanta. Now, the United States has entered a fourth wave, he argues, with the virus infiltrating mid-sized and smaller cities, undercutting the popular belief that only densely populated areas could be hard hit.  Crucially, smaller cities and rural towns may lack the hospital capacity to care for an influx of patients and may be forced to lean on bigger cities already buckling under their own caseloads.  “The disruption of the well-established chain of care that goes from community hospital to local major medical center, then to regional super-specialty care may result in the largest tragedy of all,” Sepkowitz concludes.  Critical quote: “It is highly likely that we will have—I don’t know whether you want to call it a second wave—but we will have a return of infections as we get into the next season,” Dr. Anthony Fauci said of the virus’ progression.  https://www.forbes.com/sites/marleycoyne/2020/04/02/the-us-may-be-heading-to-a-second-or-even-fourth-wave-of-the-coronavirus-epidemic-heres-what-that-means/#40402a5a16a0
    2
  247. 2
  248. Sicca syndrome: An autoimmune disease, also known as Sjogren syndrome, that classically combines dry eyes, dry mouth, and another disease of connective tissue such as rheumatoid arthritis (most common), lupus, scleroderma or polymyositis. There is a great preponderance of females. About 90% of Sjogren syndrome patients are female, usually in middle age or older. Sjogren syndrome is an inflammatory disease of glands and other tissues of the body. Inflammation of the glands that produce tears (the lacrimal glands) leads to decreased tears and dry eyes. Inflammation of the glands that produce the saliva in the mouth (salivary glands, including the parotid glands) leads to dry mouth. The syndrome can consequently be complicated by infections of the eyes, breathing passages, and mouth. Sjogren syndrome is typically associated with antibodies, antibodies produced by the body that are directed against a variety of body tissues (autoantibodies). The diagnosis of the syndrome can also be aided by a biopsy of an affected gland. The treatment of Sjogren syndrome is directed toward the particular areas of the body that are involved by the disease and the complications such as infection. The term "sicca" refers to the dryness of the eyes and mouth. The syndrome is named after the Swedish ophthalmologist Henrik Samuel Conrad Sjogren (1899-1986) who, after seeing a woman of middle age with the disease, collected 19 such cases and in his doctoral thesis in 1933 delineated the syndrome. Sjogren's thesis was not considered of sufficient importance to earn him the title of "docent", denying him a career in academic medicine. The syndrome he discovered nonetheless came to be accepted around the world. More at https://www.medicinenet.com/script/main/art.asp?articlekey=8020
    2
  249. 2
  250. 2
  251. 2
  252. 2
  253. 2
  254. 2
  255. 2
  256. 2
  257. 2
  258. 2
  259. 2
  260. 2
  261. 2
  262. 2
  263. 2
  264. 2
  265. 2
  266. 2
  267. 2
  268. Health officials worry about long-term effects of COVID-19 on kids More than one-third of all kids tested for COVID-19 in the state are testing positive. It’s even higher in Lee County at 46%. Now, some health officials are sounding the alarm about the potential longer-term effects of this virus on our kids. Health experts say we still have a lot to learn. A warning from Doctor Alina Alonso, the director of the Department of Health Palm Beach County: Just because you don’t see any COVID-19 symptoms in a child doesn’t mean damage hasn’t been done. “And while many of these especially younger children are asymptomatic when you take x-rays of their lungs, down in Miami and other places across the country, they’re seeing that there is damage to the lungs in these asymptomatic children.” While Alonso says there’s proof asymptomatic children are suffering lung damage now, she and other warn we also need to start thinking about the lasting consequences these kids may have to live with. “We may have to deal with this virus for decades because of not just the survivors coming back with consequences, but also those who were the silent, infected individuals,” said Dr. Bindu Mayi, professor of microbiology at NSU’s College of Medical Sciences. On Thursday, when asked about the issue, Governor Ron DeSantis cited a lack of studies and evidence as a reason we shouldn’t be too concerned yet. "It would be irresponsible for me to say, ‘There will never be any long term’ because we just don’t know. But it’s also problematic to say in 20 years, there’s going to be all of these problems because we just don’t know that." Instead, the governor says we should stick to the proven facts, like focusing on the best strategy to avoid infection: wearing a mask and social distancing. Experts say one reason we know so little about the virus is because of how it spreads throughout the body. It can impact multiple organs and body systems in different ways in different people. https://www.winknews.com/2020/07/17/health-officials-worry-about-long-term-effects-of-covid-19-on-kids/
    2
  269. 2
  270. Moscow's Gamaleya Institute, which created the world's first Covid-19 vaccine, has sent "detailed responses" to the questions posed by British medical journal The Lancet, after a group of scientists criticized the Russian data. On September 7, an open letter signed by twenty-six analysts, mainly based in Italy, cast doubt on Russia's vaccine, noting the discovery of "potential data inconsistencies" in the published research. The group claimed that the article had significant statistical anomalies. Following the letter, the journal's editorial board asked the developers of the Russian vaccine, dubbed Sputnik V, to reply. According to Alexey Kuznetsov, an assistant to Russia's Minister of Health, the vaccine's creators have sent "detailed responses to the editor of The Lancet magazine." The Institute, which developed and trialled Sputnik V in conjunction with Russia's Defense Ministry, had denied the accusations of discrepancies, highlighting that the research was checked by The Lancet's own reviewers. "The Gamaleya Institute categorically rejects the accusations made by a group of scientists about the inaccuracy of statistical data published in The Lancet," Deputy Research Director Denis Logunov told Russian news agency RIA Novosti. The registration of Sputnik V was announced by Russian President Vladimir Putin on August 11, who declared that the country had developed the world's first anti-coronavirus vaccine. Scheduled to be available to the general public in 2021, it is currently in the third trial stage, which will see 40,000 Muscovites receive the two shots. https://www.rt.com/russia/500370-russian-coronavirus-vaccine-lancet-questions/
    2
  271. 2
  272. 2
  273. 2
  274. 2
  275. 2
  276. 2
  277. 2
  278. 2
  279. 2
  280. 2
  281. 2
  282. 2
  283. 2
  284. 2
  285. 2
  286. 2
  287. 2
  288. 2
  289. 2
  290. 2
  291. 2
  292. 2
  293. 2
  294. 2
  295. 2
  296. 2
  297. 2
  298. 2
  299. 2
  300. 2
  301. 2
  302. 2
  303. 2
  304. 2
  305. 2
  306. 2
  307. 2
  308. 2
  309. 2
  310. 2
  311. 2
  312. Health officials worry about long-term effects of COVID-19 on kids More than one-third of all kids tested for COVID-19 in the state are testing positive. It’s even higher in Lee County at 46%. Now, some health officials are sounding the alarm about the potential longer-term effects of this virus on our kids. Health experts say we still have a lot to learn. A warning from Doctor Alina Alonso, the director of the Department of Health Palm Beach County: Just because you don’t see any COVID-19 symptoms in a child doesn’t mean damage hasn’t been done. “And while many of these especially younger children are asymptomatic when you take x-rays of their lungs, down in Miami and other places across the country, they’re seeing that there is damage to the lungs in these asymptomatic children.” While Alonso says there’s proof asymptomatic children are suffering lung damage now, she and other warn we also need to start thinking about the lasting consequences these kids may have to live with. “We may have to deal with this virus for decades because of not just the survivors coming back with consequences, but also those who were the silent, infected individuals,” said Dr. Bindu Mayi, professor of microbiology at NSU’s College of Medical Sciences. On Thursday, when asked about the issue, Governor Ron DeSantis cited a lack of studies and evidence as a reason we shouldn’t be too concerned yet. "It would be irresponsible for me to say, ‘There will never be any long term’ because we just don’t know. But it’s also problematic to say in 20 years, there’s going to be all of these problems because we just don’t know that." Instead, the governor says we should stick to the proven facts, like focusing on the best strategy to avoid infection: wearing a mask and social distancing. Experts say one reason we know so little about the virus is because of how it spreads throughout the body. It can impact multiple organs and body systems in different ways in different people. https://www.winknews.com/2020/07/17/health-officials-worry-about-long-term-effects-of-covid-19-on-kids/
    2
  313. 2
  314. 2
  315. 2
  316. 2
  317. 2
  318. 2
  319. 2
  320. 2
  321. 2
  322. 2
  323. 2
  324. 2
  325. 2
  326. 2
  327. 2
  328. 2
  329. 2
  330. 2
  331. 2
  332. 2
  333. 2
  334. 2
  335. 2
  336. 2
  337. 2
  338. 2
  339. 2
  340. 2
  341. 2
  342. 2
  343. 2
  344. 2
  345. 2
  346. 2
  347. Moscow's Gamaleya Institute, which created the world's first Covid-19 vaccine, has sent "detailed responses" to the questions posed by British medical journal The Lancet, after a group of scientists criticized the Russian data. On September 7, an open letter signed by twenty-six analysts, mainly based in Italy, cast doubt on Russia's vaccine, noting the discovery of "potential data inconsistencies" in the published research. The group claimed that the article had significant statistical anomalies. Following the letter, the journal's editorial board asked the developers of the Russian vaccine, dubbed Sputnik V, to reply. According to Alexey Kuznetsov, an assistant to Russia's Minister of Health, the vaccine's creators have sent "detailed responses to the editor of The Lancet magazine." The Institute, which developed and trialled Sputnik V in conjunction with Russia's Defense Ministry, had denied the accusations of discrepancies, highlighting that the research was checked by The Lancet's own reviewers. "The Gamaleya Institute categorically rejects the accusations made by a group of scientists about the inaccuracy of statistical data published in The Lancet," Deputy Research Director Denis Logunov told Russian news agency RIA Novosti. The registration of Sputnik V was announced by Russian President Vladimir Putin on August 11, who declared that the country had developed the world's first anti-coronavirus vaccine. Scheduled to be available to the general public in 2021, it is currently in the third trial stage, which will see 40,000 Muscovites receive the two shots. https://www.rt.com/russia/500370-russian-coronavirus-vaccine-lancet-questions/
    2
  348. 2
  349. 2
  350. 2
  351. 2
  352. 2
  353. 2
  354. 2
  355. 2
  356. 2
  357. 2
  358. 2
  359. 2
  360. 2
  361. 2
  362.  @vidznstuff1  Excerpts and corresponding links: FFP2 masks have a minimum of 94% filtration percentage and maximum 8% leakage to the inside. They are mainly used in construction, agriculture, and by healthcare professionals against influenza viruses. They are currently used for protection against the coronavirus. In Europe, for caregivers, it is necessary to wear a respirator of at least class FFP2 or FFP3 for maximum filtration of particles and aerosols when caring for a patient who is infected or suspected of being so In the United States, the N95 respirator filters 95% of airborne particles, and can even filter out bacteria and viruses, according to the Centers for Disease Control and Prevention. So for caregivers, it is necessary to wear a respirator of class N, R or P. http://emag.medicalexpo.com/which-masks-actually-protect-against-coronavirus/ ____________________________________________________________________ FFP1 Respirator masks (which means they are made of a fabric designed to filter the air or impurities) are based on a grading system do indicate how much protection they offer. First up is FFP1, which protects against materials in concentrations up to 4x OEL or 4x APF (assigned protection factor). Because it is the first rung on the ladder (so to speak), they are the most affordable option and they can be bought from UK Meds for £9.99 for one £29.99 for a pack of five. FFP2 Next is FFP2 and these offer more protection than FFP1, at concentrations up to 12x OEL or 10x APF. They are the European equivalent of the N95 respirator masks used in the US and this kind meet the guidance from the World Health Organisation (WHO). FFP3 The masks that offer the highest level of protection are FFP3, which protect against materials in concentrations up to 50x OEL or 20x APF. This is substantially higher than FFP1 and they can block both liquid and solid aerosols. Current NHS guidelines stipulate FFP3 face masks for virus and bacterial infection control when the contagion is spread through coughing and sneezing (such as with the coronavirus). They are also often used by healthcare professionals when handling hazardous pharmaceutical chemicals. https://www.ukmeds.co.uk/blog/what-s-the-difference-between-ffp1-ffp2-and-ffp3-face-masks ______________________________________________________________ However, unlike simple facemasks or surgical masks, respiratory masks protect against aqueous and oily aerosols, smoke and fine dust in. Their protective function is verified by the Europe-wide EN 149 standard and divided into FFP2 and FFP3, these standards verify protection from avian flu, SRAS, tuberculosis, as well as infection respiratory pathogens, and bacteria. The two classifications also signify the number of particulates filtered out by the mask, the FFP2 filters 94% and FFP3 filters 99%. The more particles that need to be filtered, the greater the number of filter material layers. Consequently, masks in the higher protection classes are thicker, meaning breathing resistance is higher. Particle-filtering face masks protect against particles, but not gases or vapours. Arsalan Karim, Director of Research and Development of Clinova, explains: “Right now, there’s a lot of talk about different kinds of protective masks, and which one is best. While surgical masks protect against infectious agents transmitted by droplets, they do not protect against airborne infectious agents such as viruses, so they will not prevent the wearer from being potentially infected by COVID-19. “However, the respirator face mask, which protects the wearer from aqueous and oily aerosols, smoke, and fine dust, is also more effective at protecting against airborne infectious agents such as COVID-19 and SARS. Respirator masks prevent viruses from entering the body through the mucous membranes of the mouth and nostrils.” https://www.healtheuropa.eu/are-face-masks-useful-for-stopping-the-spread-of-covid-19/99087/
    2
  363.  @vidznstuff1  Continued: An FFP mask (“Filtering Face piece Particles”) is an individual respirator protection mask. Developed as per standard NF EN 149, it is designed to protect the wearer against the inhalation of both droplets and particles suspended in the air. Wearing this type of mask is more restrictive than a surgical mask (heat-related discomfort, breathing resistance), but it protects from inhaling infectious pathogens. Available in shell, 2-ply, 3-ply and duckbill shapes, with or without an exhaling valve, with optional facial seals, there are three categories, according to their effectiveness: FFP1 masks which filter at least 80% of aerosols (inward leakage < 22%); FFP2 masks which filter at least 94% of aerosols (inward leakage < 8%); FFP3 masks which filter at least 99% of aerosols (inward leakage < 2%). https://www.afnor.org/en/news/protective-masks-faced-with-coronavirus-standard-development-bodies-follow-multiple-leads/ ____________________________________________________________ PPE MASKS (Personal Protective Equipment Mask) Their main purpose is protection of the wearer. These PPE masks - filter the inhaled air protecting the wearer and some types also filter the exhaled air (protection towards the outside) - have levels recommended by the WHO (World Health Organization): - The FFP2 filters over 92% of the suspended particles - The FFP3 arrive at values equal to or greater than 98%; - must fit tightly to the face and be worn correctly - must be worn mainly by healthcare personnel as indicated by WHO (Respiratory protective masks fall under Personal Protective Regulation. European standard EN 149 specifies performance requirements and test methods for FFP2 masks, or alternatively FFP3 (American similar standard protection levels are N95 / N99) https://www.edana.org/how-we-take-action/covid-19/protective-and-medical-face-masks ____________________________________________________________ Currently, there are two main types of face masks: surgical face masks (also known as simple face masks, like the one pictured above) and respirator masks (such as N95 respirator and other FFP2/3 forms like the one pictured below). Unlike surgical masks, which are unable to filter out virus-containing droplets, respirator masks protect against small droplets and particles including, aqueous and oily aerosols, smoke and fine dust. For this reason, respirator masks are more suitable for use during the COVID-19 pandemic. In a study published by the UK’s Health and Safety Executive, Evaluating the protection afforded by surgical masks against influenza bioaerosols[1], they found that respirators provided a much higher level of protection against viruses. The study focused on the effectiveness of surgical masks against a range of airborne particles, and through separate tests measuring “levels of inert particles and live aerosolised influenza virus”. This research is relevant now because, as with influenza, it seems that the main way the coronavirus causing Covid-19 spreads is via inhalation or contact with tiny virus filled droplets. If wearing a mask prevents a high percentage of droplets from entering your respiratory system, the benefit is clear. While masks do not guarantee 100 per cent protection for the wearer, if used correctly, they can considerably reduce the likelihood of infection. During a time when working to flatten the curve is of top priority, any reduction in transmission rates is welcome, and masks are a good option to help combat this. The results showed that, when compared to the baseline level, surgical masks produced a six-fold reduction in exposure, meaning that live virus cells could be detected in the air behind all models of mask tested. In comparison, a well-fitted respirator provided a 100-fold reduction as a minimum, providing meaningful protection from virus particles. With public demand for masks growing daily, people must be able to access these high specification masks. When masks are added into the mix of social distancing and hand washing, there can be a meaningful ‘flattening of the curve’. While that may sound like a term only of interest to statisticians, it matters to us all, as it is the concept used by virologists to indicate the reduction in rates of virus transmission. When an infected person coughs or sneezes, up to half a million virus particles can spread to those around them, so it’s never been more important to have the right protection against what is a very infectious virus. Respiratory masks On the back of this evidence, Clinova has seen a massive increase in enquiries from the public about its face mask product, COVAFLU ™ Respirator Mask. The most common question relates to the suitability and effectiveness of different mask types during the Covid-19 Pandemic. The protective function of respiratory masks is verified by the Europe-wide EN 149 standard, which verifies protection from avian flu, SARS, tuberculosis and a variety of other respiratory infectious agents. There are two classifications of respirator masks – FFP2 and FFP3, which filter up to 94 per cent and 99 per cent of particles, respectively. The more particles that need to be filtered, the greater the number of filter material layers. The different layers fulfil a variety of functions, including aesthetics, comfort, stability, tear-resistance and, of course, filtering. COVAFLU™ Respiratory Mask is an FFP2/N95 mask, which has been designed to meet World Health Organisation and Health Protection Authority standards. The mask functions by effectively blocking small virus sized particles from entering the body and comfort by making the mask adjustable, allowing the wearer to customise the fit. https://www.hospitaltimes.co.uk/know-your-mask-flu-respirator-mask-vs-surgical-face-mask/ _________________________________________________ Conclusion: When choosing face protection, the wearer should be aware that only certified respirators from a standard of KN95 or FFP2 provide protection against Covid-19. The most effective protection is wearing a respirator in combination with observing the hygiene rules. https://www.virmasko.com/en/worauf-es-beim-kauf-einer-atemschutzmaske-ankommt/ Etc., etc.
    2
  364. 2
  365. 2
  366. 2
  367. 1
  368. 1
  369. 1
  370. 1
  371. 1
  372. 1
  373. 1
  374. 1
  375. 1
  376. 1
  377. 1
  378. 1
  379. 1
  380. 1
  381. 1
  382. 1
  383. 1
  384. 1
  385. 1
  386. 1
  387. 1
  388. 1
  389. 1
  390. 1
  391. 1
  392. 1
  393. 1
  394. 1
  395. 1
  396. 1
  397. 1
  398. 1
  399. 1
  400. 1
  401. Translated from French in a Geneva newspaper article published on May 11, an excerpt: Hydroxychloroquine: not proven The antimalarial chloroquine and its derivative hydroxychloroquine, used in particular in the treatment of lupus, have an in vitro action on many viruses, including SARS-CoV-2: they create a hostile environment for the virus by increasing the pH of the cell it seeks to infect. But they have never shown effectiveness in real conditions, or even worsened the condition of patients in certain diseases. Some researchers and leaders tout this molecule, sometimes combined with an antibiotic, as a possible solution to the Covid-19 pandemic, but studies published so far do not allow to conclude. The Didier Raoult IHU Méditerranée Infection in Marseille published on Tuesday a study concluding with a low mortality rate, with eight deaths in a thousand patients (against only five in a summary of the study in early April). But this level is comparable to that observed in the case of a natural course of the disease. A study carried out in New York hospitals and published Thursday in the American journal NEJM shows that hydroxychloroquine has neither improved nor significantly deteriorated the condition of patients in serious condition. Other studies are underway in several countries. And pharmacology specialists believe that for it to work, it should be administered in extremely high doses, which would be toxic or even fatal. Health officials have also warned of serious side effects on the heart, which may be more common in people with coronavirus.
    1
  402. 1
  403. 1
  404. 1
  405. 1
  406. 1
  407. 1
  408. 1
  409. 1
  410. 1
  411. 1
  412. 1
  413. 1
  414. 1
  415. 1
  416. 1
  417.  @grahamatsea3575  The article at the link ending in 322 - one biased professor toeing his jealous western country's line... LOL! Irrelevant, really. You might find this video interesting and very informative: https://www.youtube.com/watch?v=aLI-gXJ7T5E It is painfully obvious that you don't know anything at all about Russia and have never been there, because you are merely parroting the mendacious propaganda fed you by the western mainstream media. People who don't agree with Putin or with the "party line" don't have any problems whatsoever. With regard to the alleged poisoning of Navalny: Navalny never was a threat to Putin or the Kremlin - he has barely 1% support in Russia where he has no real impact whatsoever. Germany claims that Novichok was found in Navalny's blood, in his urine and on his skin, and in a bottle he had with him when he boarded the plane in Tomsk... Now, if there really had been a poisoning, the only person or people who could have done it are a trusted cohort following the orders of Navalny's western sponsors (Putin-hating Soros and criminal Mikhail Borisovich Khodorkovsky) in view of Navalny's constant and persistent failures over the years at destabilizing Putin and the Kremlin, and who may well have thought that Navalny serves their agenda better if he dies and becomes a "martyr" than if he stays alive and well. That is if indeed there was any Novichock anywhere on Navalny, in Navalny and in that bottle, which I seriously doubt since in view of the treatment he received at the hospital in Omsk, he would have died there had he been poisoned with Novichok. Note that Navalny drank some tea during an unscheduled and unplanned stop at a coffee shop in the airport in Tomsk - there again, only someone in his entourage could have put poison in his tea, if he actually was poisoned. I mean, think about it. First, the Russians poison him with the deadliest chemical weapon in the world, then they do their best to save his life and finally send him to Germany so that the Germans could establish that he was poisoned by the Russians with the deadliest chemical weapon in the world. No one else was affected, including his assistants and entourage, and there were no protective suits around, not even on the Russian doctors who treated him. The whole thing beggars belief!
    1
  418.  @grahamatsea3575  Results of Russia's COVID-19 vaccine produced antibody response: The Lancet https://www.reuters.com/article/us-health-coronavirus-russia-vaccine/results-of-russias-covid-19-vaccine-produced-antibody-response-the-lancet-idUSKBN25V1I2 RDIF AND THE GAMALEYA NATIONAL RESEARCH CENTER OF EPIDEMIOLOGY AND MICROBIOLOGY ANNOUNCE THE PUBLICATION IN LEADING MEDICAL JOURNAL THE LANCET OF THE RESULTS OF CLINICAL TRIALS OF PHASE I-II OF THE RUSSIAN VACCINE SPUTNIK V DEMONSTRATING ITS SAFETY AND EFFICACY https://sputnikvaccine.com/newsroom/pressreleases/rdif-and-the-gamaleya-national-research-center-of-epidemiology-and-microbiology-announce-the-publica/ Russia’s Sputnik-V Vaccine Produces Antibody Response: The Lancet https://www.britishherald.com/russias-sputnik-v-vaccine-produces-antibody-response-the-lancet/ Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31866-3/fulltext Sputnik V questions ANSWERED: Head of team financing world’s first Covid-19 vaccine explains formula to critics https://sputniknews.com/columnists/202009071080382164-questions-on-russias-sputnik-v-vaccine-answered/ RDIF Highlights Safety of Russia’s Sputnik V After Oxford COVID-19 Vaccine Trials Paused https://sputniknews.com/russia/202009091080405657-rdif-highlights-safety-of-russias-sputnik-v-after-oxford-covid-19-vaccine-trials-paused/ Etc., etc.
    1
  419. 1
  420. 1
  421. 1
  422. 1
  423. 1
  424. 1
  425. 1
  426. 1
  427. 1
  428. 1
  429. 1
  430. 1
  431. 1
  432. 1
  433. 1
  434. 1
  435. 1
  436. 1
  437. 1
  438. 1
  439. 1
  440. 1
  441. 1
  442. 1
  443. 1
  444. 1
  445. 1
  446. 1
  447. 1
  448. 1
  449. 1
  450. 1
  451. 1
  452. 1
  453. 1
  454. 1
  455. 1
  456. 1
  457. 1
  458. 1
  459. 1
  460. 1
  461. 1
  462. 1
  463. 1
  464. 1
  465. https://www.nbcnews.com/health/health-news/hydroxychloroquine-covid-19-scientists-say-it-s-time-stop-promoting-n1235347 https://www.nejm.org/doi/full/10.1056/NEJMoa2019014 https://www.statnews.com/2020/07/16/new-covid-19-study-despite-flaws-adds-to-case-against-hydroxychloroquine/ https://www.acpjournals.org/doi/10.7326/M20-4207 https://theconversation.com/why-hydroxychloroquine-and-chloroquine-dont-block-coronavirus-infection-of-human-lung-cells-143234 https://www.sciencenews.org/article/covid-19-coronavirus-hydroxychloroquine-no-evidence-treatment https://www.theadvocate.com/baton_rouge/news/coronavirus/article_785b51a6-d603-11ea-b1f7-9726f23253aa.html https://medcitynews.com/2020/07/hydroxychloroquine-flunks-phase-iii-trial-in-mild-to-moderate-covid-19/ https://www.forbes.com/sites/alexledsom/2020/07/19/hydroxychloroquine-europe-turns-away-from-doctor-who-championed-drug-with-irresponsible-study/#3948cbddf912 https://www.news-medical.net/news/20200719/Hydroxychloroquine-is-not-indicated-for-COVID-19-under-any-circumstances.aspx https://www.counterpunch.org/2020/08/04/statement-from-yale-faculty-on-hydroxychloroquine-and-its-use-in-covid-19/ https://www.technologynetworks.com/drug-discovery/news/why-lopinavir-and-hydroxychloroquine-are-ineffective-in-covid-19-patients-337291 https://en.mercopress.com/2020/07/25/brazil-study-confirms-hydroxychloroquine-is-ineffective-to-treat-covid-19 https://www.pharmacytimes.com/publications/issue/2020/july2020/patient-experiences-cardiac-arrest-when-taking-2-medications https://spectrumlocalnews.com/nys/central-ny/politics/2020/07/29/ub-doctors-give-facts-about-hydroxychloroquine-and-covid https://www.ajmc.com/view/caution-strongly-recommended-when-using-chloroquine-hydroxychloroquine-in-patients-with-cardiovascular-disease-covid19 https://www.hug.ch/sites/interhug/files/structures/coronavirus/documents/hydroxy-chloroquine_et_covid-19.pdf
    1
  466. 1
  467. 1
  468. 1
  469. 1
  470. 1
  471. 1
  472. 1
  473. 1
  474. 1
  475. 1
  476. 1
  477. 1
  478. 1
  479. 1
  480. 1
  481. 1
  482. 1
  483. 1
  484. 1
  485. 1
  486. 1
  487. 1
  488. 1
  489. 1
  490. 1
  491. 1
  492. 1
  493. 1
  494. 1
  495. 1
  496. 1
  497. 1
  498. 1
  499. No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19 5 June 2020 Statement from the Chief Investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial on hydroxychloroquine, 5 June 2020 Professor Peter Horby and Professor Martin Landray, chief investigators of the RECOVERY Trial, said ‘In March this year, RECOVERY was established as a randomised clinical trial to test a range of potential drugs for COVID-19, including hydroxycholoroquine. ‘The trial has proceeded at unprecedented speed, enrolling over 11,000 patients from 175 NHS hospitals in the UK. Throughout this time, the independent Data Monitoring Committee has reviewed the emerging data about every two weeks to determine if there is evidence that would be strong enough to affect national and global treatment of COVID-19. ‘On Thursday 4 June, in response to a request from the UK Medicines and Healthcare Products Regulatory Agency (MHRA), the independent Data Monitoring Committee conducted a further review of the data. Last night, the Committee recommended the chief investigators review the unblinded data on the hydroxychloroquine arm of the trial. ‘We have concluded that there is no beneficial effect of hydroxychloroquine in patients hospitalised with COVID-19. We have therefore decided to stop enrolling participants to the hydroxychloroquine arm of the RECOVERY Trial with immediate effect. We are now releasing the preliminary results as they have important implications for patient care and public health. More at https://www.recoverytrial.net/news/statement-from-the-chief-investigators-of-the-randomised-evaluation-of-covid-19-therapy-recovery-trial-on-hydroxychloroquine-5-june-2020-no-clinical-benefit-from-use-of-hydroxychloroquine-in-hospitalised-patients-with-covid-19
    1
  500. 1
  501. I posted the following comment in one of your recent videos (a couple of days ago) with regard to Covid-19 antibodies (seroconversion) in the blood serum of people who recovered - would that not make the vaccine ineffective in many people?: *Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications * Authors measured antibodies in plasma collected from 175 COVID-19 recovered patients with mild symptoms. around 30% had very low levels of antibodies and 6% had no detectable antibodies at all, even 14 days after recovery. https://www.medrxiv.org/content/10.1101/2020.03.30.20047365v1.full.pdf Latest numbers: Netherlands Total Confirmed : 31,766 Total Deaths : 3,613 (11.37%) USA Total Confirmed : 726,645 Total Deaths : 38,664 (5.32%) Total Tested in the US: 3,690,482 UK Total Confirmed: 115,314 Total Deaths : 15,498 (13.43%) Belgium Total Confirmed : 37,183 Total Deaths j: 5,453 (14.665%) Germany Total Confirmed : 143,342 Total Deaths : 4,459 (3.11%) France Total Confirmed : 149,149 Total Deaths : 19,345 (12.97%) Ecuador Total Confirmed: 9,022 Total Deaths : 456 (5.05%) Spain Total Confirmed: 191,726 Total Deaths : 20,043 (10.45%) Italy Total Confirmed: 175,925 Total Deaths: 23,227 (13.2%) Israel Total Confirmed: 13,265 Total Deaths: 164 (1.23%) Bangladesh Total Confirmed: 2,144 Total Deaths: 84 (3.91%) Here is one of many photos of the crowds attending the funeral of Allama Maulana Zubayer Ahmed Ansari: https://tbsnews.net/sites/default/files/styles/infograph/public/images/2020/04/18/brahmanbaria_pic_18-04_3.jpg
    1
  502. 1
  503. 1
  504. 1
  505. 1
  506. 1
  507. *No, Covid-19 is not just viral pneumonia * 21.04.2020 Zurich researchers analyzed the tissue of people who died from the new coronavirus. They believe it is systemic vascular inflammation and not pneumonia. Much more than pneumonia, COVID-19 is a systemic vascular inflammation, according to a study by researchers from Zurich. This explains why it causes so many cardiovascular problems and vital organ failures. The first patients had mostly difficult-to-treat pneumonia, the University Hospital Zurich (USZ) said in a statement. Subsequently, doctors have found more and more cases of cardiovascular disorders and multiple organ failures with no apparent connection to pneumonia. Zsuzsanna Varga's team at the USZ therefore examined tissue samples from deceased patients using a microscope and found that the inflammation affected the endothelium - the inner lining of blood vessels - of different organs. The SARS-CoV-2 virus has been detected in the endothelium itself, where it kills the cells, then the affected tissues and organs. The researchers deduce that the virus attacks the immune system not by the lungs, but directly by the ACE2 receptors present in the endothelium, which thus loses its protective function. All affected organs "Covid-19 disease can affect the blood vessels of all organs," says Frank Ruschitzka, director of the USZ Cardiology Clinic, who now suggests calling this clinical picture "Covid-endothelitis." It is a systemic inflammation of the blood vessels that can affect the heart, brain, lungs, kidneys or even the digestive tract. It causes severe microperturbations in the bloodstream that can damage the heart or cause pulmonary embolism, or even obstruct blood vessels in the brain or the gastrointestinal system, says the USZ. If the endothelium of young patients defends itself well, this is not the case for the risk groups suffering from hypertension, diabetes or cardiovascular disease, the common characteristic of which is reduced endothelial function. Therapeutically, this means fighting the multiplication of the virus and at the same time protecting and stabilizing the vascular system of patients, concludes Professor Ruschitzka, quoted in the press release. These works are published in the British medical journal "The Lancet". A virus like no other Other research published in the journal “Science” goes in the same direction, evoking a systemic disease and a virus which acts in a way different from all the other pathogens seen so far. Kidney, brain and central nervous system damage has been reported, as have seizures, encephalitis and stroke in patients who have recovered. The intestines, rich in ACE2 receptors, are another front of attack: half of the patients suffer from diarrhea. The eyes and liver are also affected. (ats / nxp) Translated from https://www.tdg.ch/suisse/covid19-quune-pneumonie-virale/story/25930175
    1
  508. 1
  509. 1
  510. 1
  511. 1
  512. 1
  513. 1
  514. 1
  515. 1
  516. 1
  517. 1
  518. 1
  519. 1
  520. 1
  521. 1
  522. 1
  523. 1
  524. 1
  525. 1
  526. 1
  527. 1
  528. 1
  529. 1
  530. 1
  531. 1
  532. 1
  533. 1
  534. 1
  535. 1
  536. 1
  537. 1
  538. 1
  539. 1
  540. 1
  541. 1
  542. 1
  543. 1
  544. 1
  545. 1
  546. 1
  547. 1
  548. 1
  549. 1
  550. 1
  551. 1
  552. 1
  553. 1
  554. 1
  555. 1
  556. 1
  557. 1
  558. 1
  559. 1
  560. 1
  561. 1
  562. 1
  563. 1
  564. 1
  565. 1
  566. 1
  567. 1
  568. 1
  569. 1
  570. 1
  571. 1
  572. 1
  573. 1
  574. 1
  575. 1
  576. 1
  577. 1
  578. 1
  579. 1
  580. 1
  581. 1
  582. 1
  583. 1
  584. 1
  585. 1
  586. 1
  587. 1
  588. 1
  589. 1
  590. 1
  591. 1
  592. 1
  593. 1
  594. 1
  595. 1
  596. 1
  597. 1
  598. 1
  599. 1
  600. 1
  601. 1
  602. 1
  603. 1
  604. 1
  605. 1
  606. 1
  607. 1
  608. 1
  609. 1
  610. 1
  611. 1
  612. 1
  613. 1
  614. 1
  615. 1
  616. 1
  617. 1
  618. CoV-2 / COVID-19: State of Knowledge as of 08/04/2020 PRESENTATION OF THE VIRUS * Name = CoV2 or CoronaVirus 2 (since 02/11/2020, see ICTV) * Family / Subfamily / Genus = Coronaviridae / Orthocoronavirinae / coronavirus * Dimension: the largest of the RNA viruses with an average of 125 nm in diameter (50 to 200 nm) * Genome = positive linear RNA (very long RNA: 30 kb: 29,903 nucleotides) * Lipoprotein envelope of cellular origin * Genetic stability: 4 to 10 genetic differences have been identified between the original Wuhan CoV2 strain and those currently circulating in the population * Ancestor: A bat virus that may have mutated in the Pangolin * Homology with its CoV congeners - 50% identity with CoV from MERS-CoV in 2012 - 79.5% identity with that of SARS-CoV1 from 2002-2004 - 90% identity with a pangolin CoV (and even 99% locally at the site which ensures binding to the ACE2 cellular receptor, determining for host specificity) - 96% identity with a CoV of a Chinese bat * Contagiousness: the rate of spread is on average from 2 to 3. Explained by a significant capacity of multiplication in the organism and by the mode of transmission (aerosols, droplets of saliva, etc.). * CoV2 entry doors into our cells: - ACE 2 (Enzyme Conversion Angiotensin 2). Very present in our lungs, heart, liver, kidney, intestine. Responsible for the 1st wave of invasion of our cells by this virus - Other possible doors: CD147, CD209 (DC-SIGN), CD299 (DC SIGNR) and GRP78 which seem to be involved the 2nd wave of invasion of our cells by Cov2 * The key that allows the virus to open the ACE2 door is Protein S (spike) * The virus - ACE2 link => alteration / apoptosis of cells expressing ACE2 (Sources, The Lancet, 2020 and others) * The key that allows the virus to open the ACE2 door is Protein S (spike) * The virus - ACE2 link => alteration / apoptosis of cells expressing ACE2 (Sources, The Lancet, 2020 and others) (Translated from French, posted by the University of Sfax https://www.facebook.com/pmounivsfax/posts/125302175746724 )
    1
  619. 1
  620. 1
  621. 1
  622. 1
  623. 1
  624. 1
  625. 1
  626. 1
  627. 1
  628. 1
  629. 1
  630. 1
  631. 1
  632. 1
  633. 1
  634. 1
  635. 1
  636. 1
  637. 1
  638. 1
  639. 1
  640. 1
  641. 1
  642. 1
  643. 1
  644. 1
  645. 1
  646. 1
  647. 1
  648. 1
  649. 1
  650. 1
  651. 1
  652. 1
  653. 1
  654. 1
  655. 1
  656. 1
  657. 1
  658. 1
  659. 1
  660. 1
  661. 1
  662. 1
  663. 1
  664. 1
  665. 1
  666. 1
  667. 1
  668. 1
  669. 1
  670. 1
  671. 1
  672. 1
  673. 1
  674. 1
  675. 1
  676. 1
  677. 1
  678. 1
  679. 1
  680. 1
  681. 1
  682. 1
  683. 1
  684. 1
  685. 1
  686. 1
  687. 1
  688. 1
  689. 1
  690. 1
  691. 1
  692. 1
  693. 1
  694. What some experts have said about Sputnik V: Dr Naor Bar-Zeev International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, USA Dr. Tom Inglesby Director of the Center for Health Security of the Johns Hopkins Bloomberg School of Public Health The two studies by Logunov and colleagues have several strengths. First, adenoviruses are ubiquitous, so humans might not be immunologically naive. A second strength is the threshold for neutralisation used in the two studies. A third strength is that the vaccine, similar to other before it, induced broad immune responses. Although not specifically discussed, the results imply a T-helper1-cell-weighted response that might be important for vaccine safety, potentially reducing the risk of antibodydependent enhanced disease. A fourth strength was development of two vaccine formulations, frozen and lyophilised. A lyophilised formulation could mean stability within the existing global vaccine refrigerated cold chain that is needed to maintain vaccine efficacy from factory to recipient, a hurdle other vaccines are yet to address. Although more costly to produce at scale, product stability will maximise reach in remote terrain, a must if universal and equitable coverage is to be achieved. Prof Nadey Hakim Vice President of the British Red Cross, Vice President of the International Medical Sciences Academy The results of clinical trials of the Russian vaccine Sputnik V have demonstrated impressive results, which have now been recognized by the international medical community. The vaccine has been shown to be safe and effective with no serious side effects identified and uses a proven platform based on human adenoviral vectors, which is currently the safest mechanism for introducing the genetic code of the virus spike into the human body. This approach has been thoroughly studied not only in Russia but also internationally. Russia has a long and successful track record developing vaccines and remains a global leader in this field. We hope that the vaccine will soon become available across the world to help stop the devastating pandemic and enable people to return to normal life. Dr Muhammad Munir Lecturer in Molecular Virology at the Lancaster University There are features that make Sputnik V a promising candidate. The idea of using two different adenoviruses as vector is superior over many vaccines in the frontline. Generally, the immune system perceive the vector proteins as antigen similar to the S protein of SARS-CoV-2, so it elicit immune response against those proteins as well. If people are reimmunized (as second dose or repeated vaccine), the pre-existing immunity can compromise the efficacy of second vaccine dose. Using a vector of different nature, as is the in Sputnik V, will avoid this problem. Prof Brendan Wren Professor of Microbial Pathogenesis, London School of Hygiene & Tropical Medicine The data on the Russian vaccine studies reported in the Lancet are encouraging - demonstrating the safety and immunogenicity of the adenovirus-based COVID-19 vaccines. Polina Stepensky Chair of the Bone Marrow Transplantation and Cancer Immunotherapy Department at Hadassah hospital, Israel First I should say to Russian scientists and Russian health professionals is ‘Bravo!’. This technology and scientific approach we perfectly understand and absolutely approve. You have made a real breakthrough in science and in medicine. We are really grateful that you have done a wonderful job. It is remarkable that stable humoral as well as cell-mediated immune response is generated. This is achieved through the use of two different vectors delivering the drug and, at the same time, solving the problem of a possible neutralizing effect on the second injection. The very high efficiency of two selected adenoviruses has been proven. Thus, the platform used by the Gamaleya Institute is the correct platform. The work done inspires great respect, and the vaccine itself is worthy of study and use. Dr. Stephane Gayet Professor at Strasbourg University, doctor at Strasbourg University Hospital This is a valuable and effective vaccine that I personally look forward to. I am very interested in the work that Russian researchers have done. I realized that one of the most advanced methods was being used - the adenoviral vector method. Dr. Fabio Vilas-Boas Pinto Health Secretary of the State of Bahia The Government of the State of Bahia, in Brazil, is very pleased with the agreement signed with the Sovereign Wealth Fund of the Russian Federation, which will guarantee access to the Sputnik V vaccine for the Brazilian people, as soon as it is approved by the Brazilian national regulatory authorities. As it is a vaccine built using human adenovirus, which is one of the safest and most effective vaccine development platforms in the world, we believe that the results of the ongoing phase 3 clinical trials will confirm the data observed in phases 1 and 2. G V Prasad Co-Chairman and Managing Director of Dr. Reddy’s Laboratories We are pleased to partner with RDIF to bring the vaccine to India. The Phase I and II results have shown promise, and we will be conducting Phase-III trials in India to meet the requirements of the Indian regulators. Sputnik V vaccine could provide a credible option in our fight against COVID 19 in India. Shavkat Ismailov Chairman of LAXISAM Group of Companies Cooperation on the Sputnik V vaccine with RDIF plays an important role. The vaccine was created by Russian scientists based on advanced scientific and clinical research. Zhong Nanshan Director of the Guangzhou Institute of Respiratory Diseases, China I am highly appraised the vaccine against COVID-19, developed by the Gamaleya Center. Let me congratulate your country on the completion of the state registration procedure. Russian adenoviral vaccine is safe and should successfully complete of its clinical trials. Hildegund Ertl Professor, Vaccine & Immunotherapy Center at the Wistar Institute in Philadelphia, USA From what I’ve seen out there, they are probably the most promising platform. Ian Jones Virology professor at Reading University, United Kingdom There is enough general background data on recombinant adenovirus-based vaccines to assume the vaccine itself will be safe at the usual doses. Ashwani Mahajan National co-convener of Swadeshi Jagran Manch, India Once the efficacy issue is resolved, then the cost would be an important issue. My feeling is that on both these accounts, the Russian vaccine would pass the test.
    1
  695. 1
  696. 1
  697. 1
  698. 1
  699. 1
  700. 1
  701. 1
  702. RUSSIA https://www.worldometers.info/coronavirus/country/russia/ Dr John, I highly respect and admire you for all the work you do and have been doing for keeping us informed on Covid-19, but when it comes to Russia, you go from Dr Campbell to Mr Hyde - your prejudices against Russia are totally unfounded, misguided, and even shameful. Know that in WWII, it is Russia which won the war at a huge cost - some 27 million lives. For every five German soldier killed in WWII, the Soviet Union killed four of them. If it weren't for the Soviet Union, you'd be speaking in German and be living in a totalitarian fascist dictatorship today. https://www.counterpunch.org/2019/05/10/thank-russia-for-winning-world-war-ii/ With regard to the Victory Parades all over Russia, know that every single military participant was tested for Covid-19 and only those who tested negative were used in the parades. The Russian leadership and the Russian people are not stupid. The date of the military parades in Russia has nothing to do with any kind of political ploy with regard to the coming vote - they are not electing anybody but giving their opinion on the suggested changes in the constitution, voting whether they approve and accept these changes or not. Know that in Russia, June 24 was the date of the first military parade celebrating the victory against Germany. I think you should refrain from expressing your warped opinions about Russa but inform yourself properly instead of drinking the western mainstream media's mendacious propaganda with regard to Russia. And yes, when it comes to Russia, you very much are something of a cynic. https://www.clinicaltrialsarena.com/news/russia-covid-19-vaccine-trials/ https://abcnews.go.com/Technology/wireStory/russia-starts-clinical-trials-covid-19-vaccine-71299532 https://www.precisionvaccinations.com/vaccines/russian-covid-19-vaccine
    1
  703. 1
  704. 1
  705. 1
  706. 1
  707. 1
  708. 1
  709. 1
  710. 1
  711. 1
  712. 1
  713. 1
  714. 1
  715. 1
  716. 1
  717. 1
  718. 1
  719. 1
  720. 1
  721. 1
  722. 1
  723. 1